Back
4D Molecular Therapeutics Stock Price Chart
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
14
FDMT
4D Molecular Therapeutics
Last Price:
23.21
Seasonality Move:
-11.17%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight buying pressure.
4D Molecular Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.14 | Sell |
| 20-day SMA: | 26.91 | Sell |
| 50-day SMA: | 28.61 | Sell |
| 200-day SMA: | 19.17 | Buy |
| 8-day EMA: | 25.09 | Sell |
| 20-day EMA: | 26.68 | Sell |
| 50-day EMA: | 26.9 | Sell |
| 200-day EMA: | 21.5 | Buy |
4D Molecular Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.34 | Sell |
| Relative Strength Index (14 RSI): | 34.91 | Sell |
| Chaikin Money Flow: | 71770 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.94 - 31.78) | Sell |
| Bollinger Bands (100): | (18.23 - 29.93) | Sell |
4D Molecular Therapeutics Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for 4D Molecular Therapeutics Stock
Is 4D Molecular Therapeutics Stock a Buy?
- 4D Molecular Therapeutics share price is 23.53 while FDMT 8-day simple moving average is 25.14, which is a Sell signal.
- The stock price of FDMT is 23.53 while 4D Molecular Therapeutics 20-day SMA is 26.91, which makes it a Sell.
- 4D Molecular Therapeutics 50-day simple moving average is 28.61 while FDMT share price is 23.53, making it a Sell technically.
- FDMT stock price is 23.53 and 4D Molecular Therapeutics 200-day simple moving average is 19.17, creating a Buy signal.
FDMT Technical Analysis vs Fundamental Analysis
Sell
14
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy or a Sell?
-
4D Molecular Therapeutics stock is rated a Sell
The current 4D Molecular Therapeutics [FDMT] share price is $23.53. The Score for FDMT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
4D Molecular Therapeutics Stock Info
Market Cap:
1.17B
Price in USD:
23.53
Share Volume:
451.73K
4D Molecular Therapeutics 52-Week Range
52-Week High:
36.25
52-Week Low:
9.44
Sell
14
4D Molecular Therapeutics (FDMT)
is a Sell
4D Molecular Therapeutics Share Price Forecast
-
What is the 4D Molecular Therapeutics stock price today?
The 4D Molecular Therapeutics stock price is 23.53 USD today. -
Will FDMT stock go up or go down?
4D Molecular Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is 4D Molecular Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, 4D Molecular Therapeutics is overvalued.
Is 4D Molecular Therapeutics Stock a Buy?
- 4D Molecular Therapeutics share price is 23.53 while FDMT 8-day exponential moving average is 25.09, which is a Sell signal.
- The stock price of FDMT is 23.53 while 4D Molecular Therapeutics 20-day EMA is 26.68, which makes it a Sell.
- 4D Molecular Therapeutics 50-day exponential moving average is 26.90 while FDMT share price is 23.53, making it a Sell technically.
- FDMT stock price is 23.53 and 4D Molecular Therapeutics 200-day simple moving average is 21.50, creating a Buy signal.
Fundamental Analysis of 4D Molecular Therapeutics
Is 4D Molecular Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Technical Analysis of 4D Molecular Therapeutics
Should I short 4D Molecular Therapeutics stock?
- FDMT Moving Average Covergence Divergence (MACD) indicator is -1.34, suggesting 4D Molecular Therapeutics is a Sell
- 4D Molecular Therapeutics Relative Strength Index (RSI) is 34.91, which suggest 4D Molecular Therapeutics is oversold
- The Bollinger Bands (25) for 4D Molecular Therapeutics is (24.94 - 31.78), which suggest 4D Molecular Therapeutics is a Sell
- The Bollinger Bands (100) for 4D Molecular Therapeutics is (18.23 - 29.93), which suggest 4D Molecular Therapeutics is a Sell
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.